Cargando…

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study

BACKGROUND: Recent studies have investigated the potential of treatments that modify the gut microbiome, such as fecal microbiota transplantation and probiotics, in individuals with psychiatric illnesses. OBJECTIVE: The aim of this study was to investigate the safety, tolerability, and efficacy of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinna Meyyappan, Arthi, Forth, Evan, Milev, Roumen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817211/ https://www.ncbi.nlm.nih.gov/pubmed/35060914 http://dx.doi.org/10.2196/32234

Ejemplares similares

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
por: Forth, Evan, et al.
Publicado: (2023)

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021)

Probiotics as Adjuvant Treatment for Psychiatric Disorders: A Systematic Review
por: Forth, E. A., et al.
Publicado: (2023)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran, Anusha, et al.
Publicado: (2013)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
por: Wallace, Caroline J. K., et al.
Publicado: (2021)

The experience and impact of stigma in Saudi people with a mood disorder
por: AlAteeq, Deemah, et al.
Publicado: (2018)

Disorder-specific cognitive profiles in major depressive disorder and generalized anxiety disorder
por: Hendriks, Sanne M, et al.
Publicado: (2014)

Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder
por: Wood-Ross, Chelsea, et al.
Publicado: (2022)

Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
por: Abraham, Gaby, et al.
Publicado: (2007)

Effects, experiences, and impact of stigma on patients with bipolar disorder
por: Mileva, Viktoria R, et al.
Publicado: (2013)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Hemolacria secondary to major depressive disorder and generalized anxiety disorder: A case report
por: Razeghian Jahromi, Leila, et al.
Publicado: (2023)

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
por: Oluboka, Oloruntoba J, et al.
Publicado: (2017)

Are Worry and Rumination Specific Pathways Linking Neuroticism and Symptoms of Anxiety and Depression in Patients with Generalized Anxiety Disorder, Major Depressive Disorder and Mixed Anxiety-Depressive Disorder?
por: Merino, Hipólito, et al.
Publicado: (2016)

Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder
por: Zhou, Yongjie, et al.
Publicado: (2017)

The comparison of severity and prevalence of major depressive disorder, general anxiety disorder and eating disorders before and after bariatric surgery
por: Matini, Diana, et al.
Publicado: (2014)

Evaluation of Coronavirus Anxiety Levels and Coping Strategies of Major Depressive Disorder, Generalized Anxiety Disorder, and Panic Disorder Patients During the Covid-19 Pandemic
por: Erden, Selime Celik, et al.
Publicado: (2023)

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021)

Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

Differentiation value of miR-26b for major depressive disorder, schizophrenia, generalized anxiety disorder
por: Kong, Lingming, et al.
Publicado: (2023)

Investigation of Cognitive Distortions in Panic Disorder, Generalized Anxiety Disorder and Social Anxiety Disorder
por: Özdemir, İlker, et al.
Publicado: (2023)

Evaluation of depression and anxiety control in greek patients with major depressive disorder with/without generalized anxiety disorder and cardiovascular disease–pronoi study
por: Papanastasiou, P., et al.
Publicado: (2021)

Treatment of generalized anxiety disorder
por: Pinder, Roger M
Publicado: (2007)

Three insights on psychoneuroimmunology of mood disorders to be taken from the COVID-19 pandemic
por: Brietzke, Elisa, et al.
Publicado: (2020)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang, Kaida, et al.
Publicado: (2017)

Long noncoding RNAs: New evidence for overlapped pathogenesis between major depressive disorder and generalized anxiety disorder
por: Cui, Xuelian, et al.
Publicado: (2017)

Disorder- and emotional context-specific neurofunctional alterations during inhibitory control in generalized anxiety and major depressive disorder
por: Liu, Congcong, et al.
Publicado: (2021)

The impact of non-infection pandemic stress on depression and anxiety severity: Investigating mediation by intrusive and deliberate rumination
por: Squires, Scott D., et al.
Publicado: (2022)

Shared Decision-Making and Information Needs among People with Generalized Anxiety Disorder
por: Ramos-García, Vanesa, et al.
Publicado: (2021)

Attribution retraining group therapy for outpatients with major depression disorder, generalized anxiety disorder, and obsessive-compulsive disorder: a pilot study()
por: Wang, Chun, et al.
Publicado: (2011)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Data and alternative models describing the associations among non-infection pandemic stress, event-related rumination, depression, and anxiety
por: Hu, Mianzhi, et al.
Publicado: (2022)

Transcranial Magnetic Stimulation of the Supplementary Motor Area in the Treatment of Obsessive-Compulsive Disorder: A Multi-Site Study
por: Hawken, Emily R., et al.
Publicado: (2016)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

EFFICACY OF MEDITATION IN GENERALIZED ANXIETY DISORDER
por: Vahia, Vihang N., et al.
Publicado: (1993)

Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ddj0fda2n9gedrloihbm0839vk